ReviewThe Journal of infectious diseases2013

World Health Organization group 5 drugs for the treatment of drug-resistant tuberculosis: unclear efficacy or untapped potential?

Kelly E Dooley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.